Wolfgang Kissel

Wolfgang Dr Kissel is a seasoned professional with a diverse background spanning over 20 years in various industries and global roles.

He is the co-founder of Sanoosa Pty Ltd, where his focus is on utilizing computational technologies to revolutionize the process of drug discovery for faster and more effective results in developing medicines for cure and prevention.

With a strong emphasis on accelerating the discovery of promising compounds, Wolfgang's work at Sanoosa involves digitizing and automating the early drug discovery stages from target identification to obtaining active compounds more efficiently.

His approach aims to streamline the drug discovery process by significantly reducing timelines and costs, ultimately leading to quicker market readiness.

Throughout his career, Wolfgang has showcased expertise in implementing strategies, leading change, and building organizational capabilities, along with a passion for coaching and mentoring individuals.

His core values include credibility, collaboration, inventiveness, excellence, and customer satisfaction, which are reflected in his professional endeavors.

Educationally, Wolfgang holds a Masters (German Diplom) in Nutrition Science, along with a Dr. rer nat in Molecular Biology and Biochemistry, both attained with distinction from reputable universities.

In addition to his current role at Sanoosa Pty Ltd, Wolfgang has held key positions in organizations such as Competitive Impact, CSL Behring, mgw homes pty ltd, Melb Angels Star Pty Ltd, Valeant Pharmaceuticals, Welldoo Ltd., Hoffmann La Roche AG, and Boehringer Mannheim, among others.

His extensive experience and leadership roles in the industry highlight his ability to drive change, enhance operational efficiencies, and deliver impactful results across various sectors.